Section Arrow
DYAI.NASDAQ
- Dyadic International
Quotes are at least 15-min delayed:2025/11/16 11:03 EST
Regular Hours
Last
 0.9124
+0.0074 (+0.82%)
Day High 
0.975 
Prev. Close
0.905 
1-M High
1.2899 
Volume 
105.07K 
Bid
0.8705
Ask
1.13
Day Low
0.91 
Open
0.945 
1-M Low
0.8807 
Market Cap 
32.75M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA
20-SMA 1.07 
50-SMA 1.07 
52-W High 2.2 
52-W Low 0.711 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/-0.06
Enterprise Value
37.76M
Balance Sheet
Book Value Per Share
-0.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.50M
Operating Revenue Per Share
0.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed:2025/11/16 11:03 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.